Downloads provided by UsageCounts
Head-to-head comparison of available commercial antibodies against Cyclin-F by immunoblot (Western blot). Work reported in this report was supported in part by the ALS-Reproducible Antibody Platform (ALS-RAP). The following study was funded in part by Genome Québec's Genomics Integration Program, awarded to the research laboratory of Peter S. McPherson. This work was supported by the ALS-Reproducible Antibody Platform (ALS-RAP), a public-private partnership established by three prominent ALS charities - the ALS Association (USA), the Motor Neurone Disease Association (UK), and the ALS Society of Canada.
CCNF, P41002, amyotrophic lateral sclerosis, Cyclin-F, antibody characterization, antibody validation, F-box only protein 1, ALS-RAP
CCNF, P41002, amyotrophic lateral sclerosis, Cyclin-F, antibody characterization, antibody validation, F-box only protein 1, ALS-RAP
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 0 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
| views | 70 | |
| downloads | 24 |

Views provided by UsageCounts
Downloads provided by UsageCounts